Charles, James A <br/><br/>
Consideration of Costs and Open-label Studies of Erenumab.  [electronic resource] 

 -  JAMA neurology  02 2019 
 - 236 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>2168-6157 
<br/><br/><label>Standard No.: </label>10.1001/jamaneurol.2018.4150  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Antibodies, Monoclonal, Humanized<br/>Calcitonin Gene-Related Peptide Receptor Antagonists<br/>Humans<br/>Migraine Disorders